Variable Details
- Antihypertensive
- ACE inhibitors
- Angiotensin II receptor blockers
- Antiadrenergics
- Beta blocker medications
- Calcium chanel blocker medications
- Direct renin inhibitor medications
- Other antihypertensive medications
- Diuretic medications
- Pure diuretic medications
- Combination diuretic/hypertension medications
Available Studies
ROS, MAP, MARS, Clinical Core, LATC
Categories
Medications
Ophthalmic
Ophthalmic medication usage in last 2 weeks
| Value | Coding |
|---|---|
| 1 | (Yes) If participant was taking an ophthalmic medication at this visit |
| 0 | (No) If participant was not taking an ophthalmic medication at this visit |
Participants supplied all medications prescribed by a doctor, vitamins, supplements, and over-the-counter remedies and medicines taken in the 2 weeks prior to the evaluation. Direct visual inspection of all containers of prescription and over-the-counter agents allowed for medication documentation. Medications were subsequently coded using the Medi-Span Drug Data Base system.
Medications include:
XALATAN TIMOLOL MAL COSOPT
ARTIFIC TEAR LUMIGAN TRAVATAN
TEARS NATURA ALPHAGAN P SYSTANE
ARTIF TEARS TIMOPTIC ALPHAGAN
TRUSOPT GENTEAL TIMOPTIC-XE
PREDNISOLONE PILOCARPINE AZOPT
MURO 128 REFRESH TEAR PRED FORTE
Medi-Span. Master Drug Data Base Documentation Manual. Indianapolis, IN: Medi-Span, 1995.